APOL1 and kidney disease: new insights leading to novel therapies

Am J Kidney Dis. 2015 Jul;66(1):9-11. doi: 10.1053/j.ajkd.2015.05.005.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Apolipoprotein L1
  • Apolipoproteins / genetics*
  • Apolipoproteins / physiology
  • Black or African American / genetics*
  • Disease Progression
  • Donor Selection
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Genotype
  • Glomerulosclerosis, Focal Segmental / diagnosis
  • Glomerulosclerosis, Focal Segmental / ethnology
  • Glomerulosclerosis, Focal Segmental / genetics
  • Humans
  • Hypertension / diagnosis
  • Hypertension / physiopathology
  • Hypertension, Renal / diagnosis
  • Kidney Diseases / ethnology
  • Kidney Diseases / etiology
  • Kidney Diseases / genetics*
  • Kidney Diseases / prevention & control
  • Lipoproteins, HDL / genetics*
  • Lipoproteins, HDL / physiology
  • Renal Replacement Therapy / statistics & numerical data
  • Therapies, Investigational
  • Tissue Donors

Substances

  • APOL1 protein, human
  • Apolipoprotein L1
  • Apolipoproteins
  • Lipoproteins, HDL